Table 9 (online only):
Sensitivity analysis of differences in BP if using lowest BP vs. average BP
| BP using lowest value | BP using average value | |||||
|---|---|---|---|---|---|---|
| placebo | rhEpo | p-value | placebo* | rhEpo** | p-value | |
| Hypertension value available, n (% | 258 (56.8%) | 233 (49.7%) | 0.044 | 258 (56.8%) | 233 (49.7%) | 0.044 |
| Systolic Blood Pressure (SBP) | ||||||
| SBP < 90th percentile, n (%) | 163 (63.2%) | 168 (72.1%) | 148 (57.4%) | 157 (67.4%) | ||
| SBP 90–94th percentile, n (%) | 29 (11.2%) | 19 (8.1%) | 0.1 | 33 (12.8%) | 21 (9.0%) | 0.06 |
| SBP >=95th percentile, n (%) | 66 (25.6%) | 46 (19.7%) | 77 (29.8%) | 55 (23.6%) | ||
| Median SBP (IQR) mmHg | 98.5 (90, 106.75) | 97 (90, 104) | 0.21 | 98.75 (92, 107) | 96 (90, 104) | 0.23 |
| Diastolic Blood Pressure (DBP) | ||||||
| DBP < 90th percentile, n (%) | 117 (45.3%) | 112 (48.1%) | 102 (39.5%) | 97 (41.6%) | ||
| DBP 90–94th %ile, n (%) | 30 (11.6%) | 33 (14.1%) | 0.44 | 27 (10.5%) | 32 (13.7%) | 0.36 |
| DBP >=95th %ile, n (%) | 111 (43.0%) | 88 (37.6%) | 129 (50.0%) | 104 (44.6%) | ||
| Median DBP (IQR) mmHg | 58.0 (52.0, 65.8) | 58.0 (50.0, 66.0) | 0.49 | 60.0 (53.1, 67.5) | 59.5 (52.0, 65.0) | 0.29 |
*
155/258 (60.1%) in placebo had more than one BP.
**
134/233 (57.5%) in rhEPO group had more than one BP.